The Insight Partners published latest research study on “Needle Free Injection Systems Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Technology, Type, Usability, Site of Delivery, Application, and End User,” the market is expected to grow from US$ 131.64 million in 2021 to US$ 411.31 million by 2028; it is estimated to grow at a CAGR of 17.7% from 2022 to 2028. The growth of the needle free injection system market is primarily attributed to the increasing incidence of communicable diseases due to needlestick injuries (NSIs) and the advantages of using self-injection devices. However, higher development costs of needle free injectors compared to conventional injection systems are hindering the growth of the market.
Download sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00009273/
Crossject; INOVIO Pharmaceuticals; Zealand Pharma A/S; PharmaJet; Portal Instruments; Medical International Technologies (MIT Canada) Inc.; NuGen Medical Devices; Ferring B.V.; National Medical Products, Inc.; and Aijex Pharma International Inc. are the key companies operating in the needle free injection system market.
Based on product, the needle free injection system market is bifurcated into fillable needle free injectors and prefilled needle free injectors. The fillable needle free injectors segment held a larger share of the market in 2021. However, the prefilled needle free injectors segment is anticipated to register a higher CAGR during the forecast period. The major driving factors for the product segment’s growth are the fast drug delivery and better reproducibility of needle free injectors, error minimization, ease to use, increasing adoption and demand for prefilled needle free injectors, and increasing application of needle free injections in vaccination.
Needlestick injuries (NSIs) are one of the major concerns for most healthcare providers, and it is considered one of the most serious health and safety threats globally. According to the Centers for Disease Control and Prevention (CDC) and European Agency for Safety and Health at Work (EU-OSHA), ~385,000 and 1,000,000 NSIs are reported annually among hospital-based healthcare staff in the US and Europe, respectively. The pooled prevalence of needlestick injuries among healthcare workers in 2020 was 32.4%. Further, according to the article published by the International Journal of Environment Research & Public Health 2022, the incidence of NSIs in Saudi Arabia is highest among physicians (36%), followed by nurses (34.8%), dentists (29.2%), and medical technologists (21.1%). Thus, above-mentioned factors are boosting the growth of the needle free injection system market.
Inquiry Before Buying at: https://www.theinsightpartners.com/inquiry/TIPRE00009273/
The needle free injection system market has been positively impacted by the COVID-19 pandemic, as the need for mass vaccination and self-injectable devices has been the focus since the onset of the pandemic in December 2019. As the number of cases has increased across regions, most of the major needle free injection system market players have entered into partnerships and agreements with other industry players and government agencies and have invested in R&D to develop a needle free injection system for the disease. For instance, Crossject, a French company that has invented a no-needle medicine injection system, has won its first major contract to supply a US government agency. Moreover, in May 2022, Gerresheimer, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech, and cosmetics—invested in Portal Instruments, a US-based developer of a next-generation needle free drug delivery technology. Also, the increasing incidence of communicable diseases due to difficulties in vaccine storage, needlestick injuries, and needle phobia has led to high uptake and acceptance of needle free injection system, mainly for the screening for vaccination and insulin delivery.
The needle free injection system market is segmented into product, technology, type, usability, site of delivery, application, end user, and geography.Based on product, the market is bifurcated into fillable needle free injectors and prefilled needle free injectors. Based on technology, the market is segmented into jet-based needle free injectors, spring-based needle free injectors, microarray patch injectors, and others. Based on type, the market is segmented into liquid-based needle free injectors, projectile-based needle free injectors, and powder-based needle free injectors. Based on usability, the market is bifurcated into disposable and reusable.
By geography, the needle free injection system market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPRE00009273/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi